View Financial HealthBillionsLtd 配当と自社株買い配当金 基準チェック /06BillionsLtd配当金を支払った記録がありません。主要情報n/a配当利回り-48.6%バイバック利回り総株主利回り-48.6%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • May 11Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Apr 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩35.9b market cap, or US$24.3m).お知らせ • Apr 21Billions Co.,Ltd. announced that it has received KRW 24.999999675 billion in funding from Humasis Co. Ltd.On April 20, 2026, Billions Co.,Ltd. has closed the transaction.お知らせ • Mar 20Billions Co.,Ltd. announced that it expects to receive KRW 25.00000044 billion in fundingBillions Co.,Ltd. has announced a private placement to issue common stock of 39,215,688 at the price of KRW 225 for the gross proceeds of KRW 10,000,000,440 and Zero Coupon Series 7 Unregistered Interest Unsecured Private Convertible Bonds due April 27, 2029 for gross proceeds of KRW 15,000,000,000; aggregate gross proceeds of KRW 25,000,000,440 on March 19, 2026. The transaction involves the new investor participation of Supi Value Up New Technology Fund for 19,607,844 shares, Supi Synergy New Technology Fund for 19,607,844 shares. The transaction will happen through third party allocation. The transaction has been approved by the board of directors of the company. All the securities issued under the offering is subject to a hold period of 1 year from the date of issuance. The transaction is expected to close on April 27, 2026. Series 7 bonds - The transaction will include participation from new investor JK New Technology Investment Fund No. 5. The transaction has been approved by the board of directors of the company. All the securities issued under the offering is subject to a hold period of 1 year from the date of issuance. The transaction is expected to close on April 27, 2026, bears zero coupon rate, 4% maturity rate and matures on April 27, 2029, 100% convertible into 49,833,887 shares at a fixed conversion price of KRW 301 from April 27, 2027 to April 20, 2029.New Risk • Mar 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩22.3b market cap, or US$14.9m).お知らせ • Feb 26Billions Co.,Ltd., Annual General Meeting, Mar 30, 2026Billions Co.,Ltd., Annual General Meeting, Mar 30, 2026, at 08:30 Tokyo Standard Time. Location: conference room, 375, sowol-ro, yongsan-gu, seoul South KoreaNew Risk • Sep 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 98% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩36.3b market cap, or US$26.0m).お知らせ • Sep 11Billions Co.,Ltd. has completed a Follow-on Equity Offering in the amount of KRW 10.48 billion.Billions Co.,Ltd. has completed a Follow-on Equity Offering in the amount of KRW 10.48 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 37,105,011 Price\Range: KRW 262 Discount Per Security: KRW 4.716 Security Name: Common Shares Security Type: Common Stock Securities Offered: 2,894,989 Price\Range: KRW 262 Discount Per Security: KRW 4.716 Transaction Features: Rights Offering分析記事 • Sep 10Lacklustre Performance Is Driving Billions Co.,Ltd.'s (KOSDAQ:044480) 28% Price DropBillions Co.,Ltd. ( KOSDAQ:044480 ) shareholders won't be pleased to see that the share price has had a very rough...分析記事 • Sep 01Is BillionsLtd (KOSDAQ:044480) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...New Risk • Aug 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩16.0b market cap, or US$11.5m).Board Change • Aug 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.分析記事 • Jun 13The Market Doesn't Like What It Sees From Billions Co.,Ltd.'s (KOSDAQ:044480) Revenues Yet As Shares Tumble 30%The Billions Co.,Ltd. ( KOSDAQ:044480 ) share price has fared very poorly over the last month, falling by a substantial...New Risk • Jun 13New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩13.1b (US$9.59m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₩13.1b market cap, or US$9.59m). Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change).お知らせ • Jun 13Billions Co.,Ltd. has filed a Follow-on Equity Offering in the amount of KRW 11.6 billion.Billions Co.,Ltd. has filed a Follow-on Equity Offering in the amount of KRW 11.6 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 40,000,000 Price\Range: KRW 290 Transaction Features: Rights OfferingReported Earnings • Mar 15Full year 2024 earnings released: ₩325 loss per share (vs ₩583 profit in FY 2023)Full year 2024 results: ₩325 loss per share (down from ₩583 profit in FY 2023). Revenue: ₩41.7b (up 44% from FY 2023). Net loss: ₩12.5b (down 165% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.お知らせ • Mar 06Billions Co.,Ltd., Annual General Meeting, Mar 20, 2025Billions Co.,Ltd., Annual General Meeting, Mar 20, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 375, sowal-ro, yongsan-gu, seoul South Korea分析記事 • Dec 09Take Care Before Jumping Onto Billions Co.,Ltd. (KOSDAQ:044480) Even Though It's 27% CheaperTo the annoyance of some shareholders, Billions Co.,Ltd. ( KOSDAQ:044480 ) shares are down a considerable 27% in the...New Risk • Nov 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩16b free cash flow). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₩26.6b market cap, or US$19.3m).分析記事 • Sep 24Potential Upside For Billions Co.,Ltd. (KOSDAQ:044480) Not Without RiskWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩16b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩16b free cash flow). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₩27.9b market cap, or US$20.9m).お知らせ • May 22Humasis Co. Ltd. (KOSDAQ:A205470) completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd.Humasis Co. Ltd. (KOSDAQ:A205470) entered into an agreement to acquire 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd for KRW 48 billion on May 17, 2024. Transaction is expected to complete on May 21, 2024. Humasis Co. Ltd. (KOSDAQ:A205470) completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd on May 21, 2024.分析記事 • May 21The Market Lifts BLADE Entertainment CO.,LTD. (KOSDAQ:044480) Shares 58% But It Can Do MoreBLADE Entertainment CO.,LTD. ( KOSDAQ:044480 ) shares have had a really impressive month, gaining 58% after a shaky...New Risk • May 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 23% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩45.7b market cap, or US$33.6m).Reported Earnings • Mar 30Full year 2023 earnings released: ₩200 loss per share (vs ₩41.73 profit in FY 2022)Full year 2023 results: ₩200 loss per share (down from ₩41.73 profit in FY 2022). Revenue: ₩97.0b (up 37% from FY 2022). Net loss: ₩6.66b (down ₩8.01b from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.分析記事 • Mar 14BLADE Entertainment CO.,LTD. (KOSDAQ:044480) Might Not Be As Mispriced As It LooksBLADE Entertainment CO.,LTD.'s ( KOSDAQ:044480 ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty...New Risk • Jul 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 33% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩45.0b market cap, or US$35.3m).お知らせ • Jul 06BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in fundingOn July 4, 2023, BLADE Entertainment CO.,LTD. closed the transaction.お知らせ • Jun 22BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in fundingBLADE Entertainment CO.,LTD. announced that it will issue 1,536,098 common shares of par value, KRW 500 at a price of KRW 1,302 per share for gross proceeds of KRW 1,999,999,596 on June 21, 2023. The transaction will include participation from individual investor Sim, Hwa Seok. The company will issue shares through third party allocation increase. The payment date for shares is July 4, 2023. The dividend date for new shares is January 1, 2023. The transaction has been approved by board of directors of the company. The shares are subject to a mandatory hold period of one year. The total number of shares issued prior to transaction are 32,555,844 shares.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 16Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd.On April 15, 2021, Blueberry NFT CO.,LTD. (KOSDAQ:A044480) closed the transaction.お知らせ • Mar 11Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd.Kyung Nam Biopharma CO.,LTD. (KOSDAQ:A044480) announced a private placement of 5,194,805 common shares at an issue price of KRW 1,925 per share for gross proceeds of KRW 9,999,999,625 on March 10, 2021. The transaction will involve participation from existing investor, Jangsan Co., Ltd. The shares have face value of KRW 500. The shares are issued at a discount of 10%. The company will issue shares through third-party allotment method. Post the closing, the total number of shares issued by the company will increase from 20,127,806 shares to 25,322,611 shares. The shares will have one-year retention period. The payment date is April 15, 2021. The listing date is May 3, 2021. The transaction has been approved by the board of directors of the company.Is New 90 Day High Low • Mar 09New 90-day low: ₩2,140The company is down 39% from its price of ₩3,515 on 09 December 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.分析記事 • Feb 04Would Shareholders Who Purchased Kyung Nam BiopharmaLTD's (KOSDAQ:044480) Stock Five Years Be Happy With The Share price Today?Kyung Nam Biopharma CO.,LTD. ( KOSDAQ:044480 ) shareholders should be happy to see the share price up 11% in the last...Is New 90 Day High Low • Jan 29New 90-day low: ₩3,000The company is down 5.0% from its price of ₩3,170 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period.Is New 90 Day High Low • Dec 16New 90-day high: ₩3,895The company is up 2.0% from its price of ₩3,815 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.分析記事 • Dec 13We Think KyungNam BiopharmaLTD (KOSDAQ:044480) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is New 90 Day High Low • Oct 20New 90-day low: ₩3,220The company is down 41% from its price of ₩5,450 on 22 July 2020. The South Korean market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 4.0% over the same period.決済の安定と成長配当データの取得安定した配当: A044480の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A044480の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場BillionsLtd 配当利回り対市場A044480 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A044480)n/a市場下位25% (KR)1.0%市場トップ25% (KR)3.8%業界平均 (Entertainment)1.0%アナリスト予想 (A044480) (最長3年)n/a注目すべき配当: A044480は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: A044480は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: A044480の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A044480が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 22:07終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Billions Co.,Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 11Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Apr 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩35.9b market cap, or US$24.3m).
お知らせ • Apr 21Billions Co.,Ltd. announced that it has received KRW 24.999999675 billion in funding from Humasis Co. Ltd.On April 20, 2026, Billions Co.,Ltd. has closed the transaction.
お知らせ • Mar 20Billions Co.,Ltd. announced that it expects to receive KRW 25.00000044 billion in fundingBillions Co.,Ltd. has announced a private placement to issue common stock of 39,215,688 at the price of KRW 225 for the gross proceeds of KRW 10,000,000,440 and Zero Coupon Series 7 Unregistered Interest Unsecured Private Convertible Bonds due April 27, 2029 for gross proceeds of KRW 15,000,000,000; aggregate gross proceeds of KRW 25,000,000,440 on March 19, 2026. The transaction involves the new investor participation of Supi Value Up New Technology Fund for 19,607,844 shares, Supi Synergy New Technology Fund for 19,607,844 shares. The transaction will happen through third party allocation. The transaction has been approved by the board of directors of the company. All the securities issued under the offering is subject to a hold period of 1 year from the date of issuance. The transaction is expected to close on April 27, 2026. Series 7 bonds - The transaction will include participation from new investor JK New Technology Investment Fund No. 5. The transaction has been approved by the board of directors of the company. All the securities issued under the offering is subject to a hold period of 1 year from the date of issuance. The transaction is expected to close on April 27, 2026, bears zero coupon rate, 4% maturity rate and matures on April 27, 2029, 100% convertible into 49,833,887 shares at a fixed conversion price of KRW 301 from April 27, 2027 to April 20, 2029.
New Risk • Mar 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩22.3b market cap, or US$14.9m).
お知らせ • Feb 26Billions Co.,Ltd., Annual General Meeting, Mar 30, 2026Billions Co.,Ltd., Annual General Meeting, Mar 30, 2026, at 08:30 Tokyo Standard Time. Location: conference room, 375, sowol-ro, yongsan-gu, seoul South Korea
New Risk • Sep 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 98% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Shareholders have been substantially diluted in the past year (98% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩36.3b market cap, or US$26.0m).
お知らせ • Sep 11Billions Co.,Ltd. has completed a Follow-on Equity Offering in the amount of KRW 10.48 billion.Billions Co.,Ltd. has completed a Follow-on Equity Offering in the amount of KRW 10.48 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 37,105,011 Price\Range: KRW 262 Discount Per Security: KRW 4.716 Security Name: Common Shares Security Type: Common Stock Securities Offered: 2,894,989 Price\Range: KRW 262 Discount Per Security: KRW 4.716 Transaction Features: Rights Offering
分析記事 • Sep 10Lacklustre Performance Is Driving Billions Co.,Ltd.'s (KOSDAQ:044480) 28% Price DropBillions Co.,Ltd. ( KOSDAQ:044480 ) shareholders won't be pleased to see that the share price has had a very rough...
分析記事 • Sep 01Is BillionsLtd (KOSDAQ:044480) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
New Risk • Aug 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩16.0b market cap, or US$11.5m).
Board Change • Aug 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
分析記事 • Jun 13The Market Doesn't Like What It Sees From Billions Co.,Ltd.'s (KOSDAQ:044480) Revenues Yet As Shares Tumble 30%The Billions Co.,Ltd. ( KOSDAQ:044480 ) share price has fared very poorly over the last month, falling by a substantial...
New Risk • Jun 13New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩13.1b (US$9.59m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₩13.1b market cap, or US$9.59m). Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change).
お知らせ • Jun 13Billions Co.,Ltd. has filed a Follow-on Equity Offering in the amount of KRW 11.6 billion.Billions Co.,Ltd. has filed a Follow-on Equity Offering in the amount of KRW 11.6 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 40,000,000 Price\Range: KRW 290 Transaction Features: Rights Offering
Reported Earnings • Mar 15Full year 2024 earnings released: ₩325 loss per share (vs ₩583 profit in FY 2023)Full year 2024 results: ₩325 loss per share (down from ₩583 profit in FY 2023). Revenue: ₩41.7b (up 44% from FY 2023). Net loss: ₩12.5b (down 165% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.
お知らせ • Mar 06Billions Co.,Ltd., Annual General Meeting, Mar 20, 2025Billions Co.,Ltd., Annual General Meeting, Mar 20, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 375, sowal-ro, yongsan-gu, seoul South Korea
分析記事 • Dec 09Take Care Before Jumping Onto Billions Co.,Ltd. (KOSDAQ:044480) Even Though It's 27% CheaperTo the annoyance of some shareholders, Billions Co.,Ltd. ( KOSDAQ:044480 ) shares are down a considerable 27% in the...
New Risk • Nov 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩16b free cash flow). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₩26.6b market cap, or US$19.3m).
分析記事 • Sep 24Potential Upside For Billions Co.,Ltd. (KOSDAQ:044480) Not Without RiskWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩16b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩16b free cash flow). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₩27.9b market cap, or US$20.9m).
お知らせ • May 22Humasis Co. Ltd. (KOSDAQ:A205470) completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd.Humasis Co. Ltd. (KOSDAQ:A205470) entered into an agreement to acquire 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd for KRW 48 billion on May 17, 2024. Transaction is expected to complete on May 21, 2024. Humasis Co. Ltd. (KOSDAQ:A205470) completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. (KOSDAQ:A044480) from Metaplex Co., Ltd. and Flake Co., Ltd on May 21, 2024.
分析記事 • May 21The Market Lifts BLADE Entertainment CO.,LTD. (KOSDAQ:044480) Shares 58% But It Can Do MoreBLADE Entertainment CO.,LTD. ( KOSDAQ:044480 ) shares have had a really impressive month, gaining 58% after a shaky...
New Risk • May 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 23% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩45.7b market cap, or US$33.6m).
Reported Earnings • Mar 30Full year 2023 earnings released: ₩200 loss per share (vs ₩41.73 profit in FY 2022)Full year 2023 results: ₩200 loss per share (down from ₩41.73 profit in FY 2022). Revenue: ₩97.0b (up 37% from FY 2022). Net loss: ₩6.66b (down ₩8.01b from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
分析記事 • Mar 14BLADE Entertainment CO.,LTD. (KOSDAQ:044480) Might Not Be As Mispriced As It LooksBLADE Entertainment CO.,LTD.'s ( KOSDAQ:044480 ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty...
New Risk • Jul 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 33% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩45.0b market cap, or US$35.3m).
お知らせ • Jul 06BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in fundingOn July 4, 2023, BLADE Entertainment CO.,LTD. closed the transaction.
お知らせ • Jun 22BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in fundingBLADE Entertainment CO.,LTD. announced that it will issue 1,536,098 common shares of par value, KRW 500 at a price of KRW 1,302 per share for gross proceeds of KRW 1,999,999,596 on June 21, 2023. The transaction will include participation from individual investor Sim, Hwa Seok. The company will issue shares through third party allocation increase. The payment date for shares is July 4, 2023. The dividend date for new shares is January 1, 2023. The transaction has been approved by board of directors of the company. The shares are subject to a mandatory hold period of one year. The total number of shares issued prior to transaction are 32,555,844 shares.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 16Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd.On April 15, 2021, Blueberry NFT CO.,LTD. (KOSDAQ:A044480) closed the transaction.
お知らせ • Mar 11Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd.Kyung Nam Biopharma CO.,LTD. (KOSDAQ:A044480) announced a private placement of 5,194,805 common shares at an issue price of KRW 1,925 per share for gross proceeds of KRW 9,999,999,625 on March 10, 2021. The transaction will involve participation from existing investor, Jangsan Co., Ltd. The shares have face value of KRW 500. The shares are issued at a discount of 10%. The company will issue shares through third-party allotment method. Post the closing, the total number of shares issued by the company will increase from 20,127,806 shares to 25,322,611 shares. The shares will have one-year retention period. The payment date is April 15, 2021. The listing date is May 3, 2021. The transaction has been approved by the board of directors of the company.
Is New 90 Day High Low • Mar 09New 90-day low: ₩2,140The company is down 39% from its price of ₩3,515 on 09 December 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.
分析記事 • Feb 04Would Shareholders Who Purchased Kyung Nam BiopharmaLTD's (KOSDAQ:044480) Stock Five Years Be Happy With The Share price Today?Kyung Nam Biopharma CO.,LTD. ( KOSDAQ:044480 ) shareholders should be happy to see the share price up 11% in the last...
Is New 90 Day High Low • Jan 29New 90-day low: ₩3,000The company is down 5.0% from its price of ₩3,170 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period.
Is New 90 Day High Low • Dec 16New 90-day high: ₩3,895The company is up 2.0% from its price of ₩3,815 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 8.0% over the same period.
分析記事 • Dec 13We Think KyungNam BiopharmaLTD (KOSDAQ:044480) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Is New 90 Day High Low • Oct 20New 90-day low: ₩3,220The company is down 41% from its price of ₩5,450 on 22 July 2020. The South Korean market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 4.0% over the same period.